Evening of 27th June 2017<br >BIOTECH AGORA<br >PRE-IPO, INVEST SECURITIES

Evening of 27th June 2017
BIOTECH AGORA
PRE-IPO, INVEST SECURITIES

NH TherAguix Conference & Cocktail

Presentation by the managemet of NH TherAguix,​​a pharmaceutical company developing innovative nanomedicine that improves the effectiveness of radiotherapy and reduces side effects without changing clinical practice. Its AGuIX® drug, in clinical phase 1, is a non-invasive, personalized solution that improves cancer imaging and treatment

Access to documents